Condensed Consolidated Statements of Cash Flows (Parenthetical) (USD $)	170 Months Ended	9 Months Ended		170 Months Ended
	Sep. 30, 2013	Sep. 30, 2013 MultiGen Diagnostics, Inc.	Sep. 30, 2012 MultiGen Diagnostics, Inc.	Sep. 30, 2013 MultiGen Diagnostics, Inc.
Condensed Consolidated Statements of Cash Flows
Interest rate, convertible debenture (as a percent)	6.00%
Issuance of common stock for Board of Directors' fees in lieu of cash payment, shares	41,750
Conversion of debentures (in dollars)	$ 2,335,050
Statement
Common stock issued in connection with an asset purchase agreement (in shares)		125,000	125,000	125,000